Article -> Article Details
Title | Nano Biotechnology Market Overview, Share and Development by 2020-2027 |
---|---|
Category | Fitness Health --> News & Media |
Meta Keywords | Nano Biotechnology Market |
Owner | vinit |
Description | |
Market Highlights According to MRFR analysis, the global nano
biotechnology market is expected to register a CAGR of~10.0% from
2021 to 2027 and hold a value of over ~USD 9,500million in2027. The global nano biotechnology market is driven by several factors,
suchas increasing investment in nano biotechnology research and high demand for
treatment of critical diseases. Nanobiotechnology is the interface of
nanotechnology and biotechnology that includes special physicochemical and
biological properties of nanostructures and their applications in numerous
fields such as medicine and agriculture. Nanobiotechnology is one of the most
promising technologies in the 21st century. It plays a significant role in
developing and implementing many useful tools in the study of life. Its
application in medicine involves disease diagnosis, target specific drug
delivery and molecular imaging. It used in agriculture and food sectorsand is
used in nanofertilizers, nanoinsectisides, nanopestisides, and othersuch
chemicals. Regional Analysis North America is likely to dominate the nano biotechnology
market, owing to high investment in the R&D projects, new product
development, government initiatives for strengthening healthcare system, and
increasing demand from end users. The pharmaceutical companies in the US are
investing heavily in R&D activities for medicines and medical devices.
Rising prevalence of chronic diseases such as cardiovascular diseases has led
to a huge demand for innovative treatment options for such diseases. This has
triggered the companies to invest in R&D activities to develop new advanced
products Europeis likely to account a significant share in the nano
biotechnology market due to high demand for technological advanced products and
established R&D facilities across the region. In addition, countries such
as Germany, Sweden, the UK, France, and Switzerland are also investing heavily
in R&D activities for nanobiotechnology. Asia-Pacific is anticipated to be the fastest-growing
regional market during the forecast period due to increasing investment in
healthcare infrastructure andrising prevalence of chronic diseases such as
cardiovascular and neurological diseases. In addition, increasing government
funding for strengthening healthcare system is creating opportunities for the
industry players. Furthermore, the growth of the market in the Rest of the
World is attributed to the technological advancements in medical science and
the increasing funding for development of healthcare infrastructutre throughout
the region Segmentation The global nano biotechnology market has been segmented into
application and therapeutics. By application, the market has been segmented into
pharmaceuticals, medical devices, medical research, and food and
agriculture.The pharmaceutical segment heldthelargest share of the market in
2020, due to high investments in R&D activities for the development of
innovative drugs for treatment of chronic diseases. Based on therapeutics, the global nano biotechnology market
has been classified asdental therapies, cardiac therapies, orthopedic
therapies, and others. The cardiac therapies segment held the largest segment
share in 2020, due to the risingprevalence of cardiovascular disorders across
the globe. Key Players Some of the key players in the global nano biotechnology
marketareAblynx (Belgium), Nami Therapeutics (US), Celgene Corporation (US),
Nanophase Technologies Corporation (US), Sigma-Aldrich (US), SkyePharma
Pharmaceuticals (France), Nano Bridging Molecules SA (Switzerland), XanTec
bioanalytics GmbH (Germany), Nanobiotix (France), and Dabur Pharma (India). |